Search: id:"swepub:oai:lup.lub.lu.se:89dd3759-5a87-403a-96aa-308079027209" >
RHAPSODY, Biomarker...
-
Adams, RachelJanssen UK
(author)
RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes
- Article/chapterEnglish2021
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:89dd3759-5a87-403a-96aa-308079027209
-
https://lup.lub.lu.se/record/89dd3759-5a87-403a-96aa-308079027209URI
-
https://doi.org/10.1002/edm2.207DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Developing a novel therapeutic product for the treatment of type 2 diabetes (T2D) is a long, resource-intensive process. Novel biomarkers could potentially aid clinical trial design by shortening clinical trials or enabling better prediction of at-risk populations and/or disease progression. Novel clinical trial designs could lead to reduced costs of development and less burden to patients, due to shorter trial duration, and/or less burdensome assessments.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Daly, NicoleJanssen UK
(author)
-
Robertson, ElizabethDiabetes UK
(author)
-
Giordano, Giuseppe N.Lund University,Lunds universitet,Genetisk och molekylär epidemiologi,Forskargrupper vid Lunds universitet,Genetic and Molecular Epidemiology,Lund University Research Groups,Skåne University Hospital(Swepub:lu)med-geg
(author)
-
Janssen UKDiabetes UK
(creator_code:org_t)
Related titles
-
In:Endocrinology, Diabetes and Metabolism: Wiley4:22398-9238
Internet link
Find in a library
To the university's database